Catherine Leger
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Surgical Treatments
-
- Genetic factors in colorectal cancer
Papers in
- Oncology 9
- Colorectal Cancer Treatments and Studies 9
- Cancer Treatment and Pharmacology 4
- Pancreatic and Hepatic Oncology Research 2
-
- Gastric Cancer Management and Outcomes 4
- Lung Cancer Treatments and Mutations 1
- Co-authors
- Josep Tabernero (8 shared papers)Nadia Amellal (8 shared papers)Eric Van Cutsem (5 shared papers)Gerald W. Prager (4 shared papers)Fortunato Ciardiello (3 shared papers)Julien Taı̈eb (3 shared papers)Marwan Fakih (3 shared papers)Elena Élez (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Future Oncology (1 paper)Entreprises et histoire (1 paper)European Journal of Cancer (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- FranceSpainUnited States
In The Last Decade
Catherine Leger
9 papers receiving 281 citations
Catherine Leger's Hit Papers
Peers
Comparison fields: 5 of 38
- Oncology 211
- Pathology and Forensic Medicine 50
- Cancer Research 30
- Pulmonary and Respiratory Medicine 63
- Hepatology 13
Countries citing papers authored by Catherine Leger
This map shows the geographic impact of Catherine Leger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Leger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Leger more than expected).
Fields of papers citing papers by Catherine Leger
This network shows the impact of papers produced by Catherine Leger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Leger. The network helps show where Catherine Leger may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine Leger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer Hit paper breakdown → | 2023 | 206 |
| 2 | 2021 | 33 | |
| 3 | 2023 | 28 | |
| 4 | 2019 | 8 | |
| 5 | 2019 | 4 | |
| 6 | 2018 | 4 | |
| 7 | 2017 | 2 | |
| 8 | 2017 | 1 | |
| 9 | 2020 | 1 | |
| 10 | 1996 | 1 |
About Catherine Leger
Catherine Leger is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Management of Technology and Innovation and Archeology, having authored 10 papers that have together received 288 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (9 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer Treatment and Pharmacology (4 papers), Pancreatic and Hepatic Oncology Research (2 papers), Genetic factors in colorectal cancer (2 papers), Lung Cancer Treatments and Mutations (1 paper), Family Business Performance and Succession (1 paper) and Cultural Identity and Heritage (1 paper). The work is most often cited by research in Oncology (211 citations), Pathology and Forensic Medicine (50 citations), Cancer Research (30 citations), Pulmonary and Respiratory Medicine (63 citations) and Hepatology (13 citations). Catherine Leger has collaborated with scholars based in France, Spain and United States. Frequent co-authors include Josep Tabernero, Nadia Amellal, Eric Van Cutsem, Gerald W. Prager, Fortunato Ciardiello, Julien Taı̈eb, Marwan Fakih, Elena Élez, Igor Bondarenko and Karim A. Benhadji. Their work appears in journals such as Journal of Clinical Oncology, Future Oncology, Entreprises et histoire, European Journal of Cancer and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.